ArticleScience translational medicine2022

A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.

Chih-Jen Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.